Virtue Capital Management’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,200	Closed	-$332K	–	365
2025 Q4	$332K	Sell	1,200 -2,432	-67%	-$665K	0.05%	224
2025 Q3	$217K	Buy	3,632 +2,126	+141%	+$517K	0.03%	280
2025 Q2	$330K	Sell	1,506 -178	-11%	-$38.1K	0.06%	186
2025 Q1	$377K	Buy	1,684 +453	+37%	+$125K	0.04%	312
2024 Q4	$403K	Buy	1,231 +164	+15%	+$51.6K	0.08%	172
2024 Q3	$320K	Buy	1,067 +242	+29%	+$74.1K	0.06%	192
2024 Q2	$261K	Buy	825 +61	+8%	+$21.6K	0.04%	308
2024 Q1	$292K	Buy	764 +2	+0.3%	+$740	0.05%	296
2023 Q4	$258K	Sell	762 -1,559	-67%	-$552K	0.05%	307
2023 Q3	$875K	Hold	2,321	–	–	0.15%	126
2023 Q2	$875K	Sell	2,321 -330	-12%	-$118K	0.15%	126
2023 Q1	$947K	Buy	2,651 +1,674	+171%	+$489K	0.16%	112
2022 Q4	$230K	Buy	+977	New	+$232K	0.04%	337
2022 Q2	–	Sell	-4,194	Closed	-$1.72M	–	415
2022 Q1	$1.72M	Sell	4,194 -1,228	-23%	-$481K	0.27%	82
2021 Q4	$2.54M	Buy	5,422 +658	+14%	+$283K	0.38%	56
2021 Q3	$2.02M	Buy	4,764 +30	+0.6%	+$12.6K	0.36%	59
2021 Q2	$1.7M	Sell	4,734 -492	-9%	-$163K	0.34%	66
2021 Q1	$1.47M	Buy	5,226 +115	+2%	+$32.9K	0.35%	68
2020 Q4	$1.45M	Sell	5,111 -386	-7%	-$108K	0.36%	77
2020 Q3	$1.51M	Sell	5,497 -536	-9%	-$142K	0.37%	77
2020 Q2	$1.37M	Buy	+6,033	New	+$1.19M	0.32%	92
2020 Q1	–	Sell	-4,044	Closed	-$608K	–	215
2019 Q4	$608K	Buy	4,044 +1,220	+43%	+$178K	0.18%	113
2019 Q3	$400K	Buy	2,824 +1,126	+66%	+$155K	0.13%	162
2019 Q2	$213K	Buy	+1,698	New	+$200K	0.08%	201